跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 845 条关于
“Polypoidal Choroidal Vasculopathy”
全部
845
临床试验
738
药物
9
机构
1
资讯
97
去年
Roche's Vabysmo Gains Reimbursement in China, Eyes Expansion in Asia
去年
Avirmax Biopharma Doses First Patient in Phase I/IIa Trial of ABI-110 for Wet AMD
去年
Avirmax Biopharma Doses First Patient in Phase I/IIa Trial of ABI-110 Gene Therapy for Wet AMD and PCV
去年
Roche's Vabysmo Shows Sustained Efficacy Over Four Years in Neovascular AMD and Delivers Vision Gains in Difficult-to-Treat Asian Subtype
去年
Five-Year Study Shows Aflibercept Treat-and-Extend Regimen Maintains Vision in Neovascular AMD Patients
2个月前
Jingze Bio Files Third HKEX IPO Application, Spotlighting Biosimilar Competition in China's Fertility and Ophthalmology Markets
2个月前
Choroidal Medium-Large Vascular Index Identified as Optimal OCT-A Biomarker for Thyroid Eye Disease Activity
去年
Aura Biosciences' Bel-sar Shows Promise in Choroidal Melanoma and Bladder Cancer Trials
2年前
Aura Biosciences' Bel-Sar Shows Promise in Phase 2 for Early-Stage Choroidal Melanoma
去年
Aura Biosciences Advances Bel-Sar in Multiple Clinical Trials for Ocular and Bladder Cancers
第 1 页，共 10 页
上一页
下一页
